Human Genome Sciences HGSI Options Theft on the Opening Bell Morning Market Snapshot: March 10th, 2011 Bear Raid Derail on HGSI on Benlysta Approval Huge Short Squeeze Expected FDA Approves Human Genome ( HGSI ), Glaxo Drug Benlysta The first new drug to treat lupus in over 50 years won U.S. approval on Wednesday. Human Genome Sciences, Inc. ( HGSI ) and GlaxoSmithKline PLC (GSK) said that. Everything Gold: Human Genome Sciences' ( HGSI ) Lupus Drug Approved Human Genome Sciences (NASDAQ: HGSI ) had its lupus drug named Benlysta approved by the U.S. Food and Drug Administration; the first lupus drug approval in over 50 years. Dr. Gary Gilkeson, chairman of the Lupus Foundation of America’s … Top Active Trader Alert Stocks (GMCR, HGSI , SBUX) | eWallstreeter Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Green Mountain Coffee Roasters Inc. (NASDAQ: GMCR), Human Genome Sciences (NASDAQ: HGSI ), and Starbucks … Human Genome Sciences ( HGSI ) is reiterated as a “Overweight … Equities research analysts at Barclays Capital Reiterate a Overweight rating for shares of Human Genome Sciences (NASDAQ: HGSI ) in a research note released to. FDA Approves Human Genome ( HGSI ), Glaxo Drug Benlysta | www … Human Genome Sciences, Inc. ( HGSI ) and GlaxoSmithKline PLC (GSK) said that the U.S. Food and Drug Administration [FDA] has approved ‘Benlysta’, an injectable drug designed to relieve flare-ups and pain caused by the disabling disease. … lifeajoke says: peter king, hca, chuck norris facts, julianne moore, hgsi , …: peter king hca chuck norris facts julianne moore…